Suppr超能文献

系统性硬化症患者的血浆D-二聚体浓度

Plasma D-dimer concentration in patients with systemic sclerosis.

作者信息

Lippi Giuseppe, Volpe Alessandro, Caramaschi Paola, Salvagno Gian Luca, Montagnana Martina, Guidi Gian Cesare

机构信息

Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Verona, Italy.

出版信息

Thromb J. 2006 Jan 18;4:2. doi: 10.1186/1477-9560-4-2.

Abstract

BACKGROUND

Systemic sclerosis (SSc) is an autoimmune disorder of the connective tissue characterized by widespread vascular lesions and fibrosis. Little is known so far on the activation of the hemostatic and fibrinolytic systems in SSc, and most preliminary evidences are discordant.

METHODS

To verify whether SSc patients might display a prothrombotic condition, plasma D-dimer was assessed in 28 consecutive SSc patients and in 33 control subjects, matched for age, sex and environmental habit.

RESULTS AND DISCUSSION

When compared to healthy controls, geometric mean and 95% confidence interval (IC95%) of plasma D-dimer were significantly increased in SSc patients (362 ng/mL, IC 95%: 361-363 ng/mL vs 229 ng/mL, IC95%: 228-231 ng/mL, p = 0.005). After stratifying SSc patients according to disease subset, no significant differences were observed between those with limited cutaneous pattern and controls, whereas patients with diffuse cutaneous pattern displayed substantially increased values. No correlation was found between plasma D-dimer concentration and age, sex, autoantibody pattern, serum creatinine, erythrosedimentation rate, nailfold videocapillaroscopic pattern and pulmonary involvement.

CONCLUSION

We demonstrated that SSc patients with diffuse subset are characterized by increased plasma D-dimer values, reflecting a potential activation of both the hemostatic and fibrinolytic cascades, which might finally predispose these patients to thrombotic complications.

摘要

背景

系统性硬化症(SSc)是一种结缔组织自身免疫性疾病,其特征为广泛的血管病变和纤维化。目前对于SSc患者止血和纤溶系统的激活了解甚少,大多数初步证据存在分歧。

方法

为了验证SSc患者是否可能存在血栓形成倾向,对28例连续的SSc患者和33例年龄、性别及环境习惯相匹配的对照者进行了血浆D-二聚体评估。

结果与讨论

与健康对照相比,SSc患者血浆D-二聚体的几何均值及95%置信区间(IC95%)显著升高(362 ng/mL,IC95%:361 - 363 ng/mL 对比229 ng/mL,IC95%:228 - 231 ng/mL,p = 0.005)。根据疾病亚型对SSc患者进行分层后,局限性皮肤型患者与对照者之间未观察到显著差异,而弥漫性皮肤型患者的值显著升高。血浆D-二聚体浓度与年龄、性别、自身抗体模式、血清肌酐、红细胞沉降率、甲襞视频毛细血管镜模式及肺部受累情况之间未发现相关性。

结论

我们证明弥漫性亚型的SSc患者血浆D-二聚体值升高,反映了止血和纤溶级联反应的潜在激活,这最终可能使这些患者易发生血栓并发症。

相似文献

1
Plasma D-dimer concentration in patients with systemic sclerosis.
Thromb J. 2006 Jan 18;4:2. doi: 10.1186/1477-9560-4-2.
2
Plasma D-dimer concentration in patients with systemic sclerosis.
Br J Dermatol. 2008 Feb;158(2):392-5. doi: 10.1111/j.1365-2133.2007.08313.x. Epub 2007 Nov 19.
3
The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis.
Clin Appl Thromb Hemost. 2018 Sep;24(6):920-927. doi: 10.1177/1076029617736382. Epub 2017 Nov 12.
4
Lipoprotein[a] and the lipid profile in patients with systemic sclerosis.
Clin Chim Acta. 2006 Feb;364(1-2):345-8. doi: 10.1016/j.cca.2005.07.015. Epub 2005 Aug 19.
5
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Rheumatology (Oxford). 2004 Jun;43(6):719-26. doi: 10.1093/rheumatology/keh156. Epub 2004 Mar 16.
7
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
Br J Rheumatol. 1997 Oct;36(10):1045-50. doi: 10.1093/rheumatology/36.10.1045.
10
Aortic pulse wave velocity measurement in systemic sclerosis patients.
Reumatismo. 2012 Dec 20;64(6):360-7. doi: 10.4081/reumatismo.2012.360.

引用本文的文献

1
The Crossroads of the Coagulation System and the Immune System: Interactions and Connections.
Int J Mol Sci. 2023 Aug 8;24(16):12563. doi: 10.3390/ijms241612563.
2
An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers.
Front Cardiovasc Med. 2022 Jul 14;9:924873. doi: 10.3389/fcvm.2022.924873. eCollection 2022.

本文引用的文献

1
Do haemostasis activation markers that predict cardiovascular disease exist?
Pathophysiol Haemost Thromb. 2003;33(5-6):302-8. doi: 10.1159/000083818.
2
Vascular involvement in systemic sclerosis (SSc).
Clin Exp Rheumatol. 2004 Jan-Feb;22(3 Suppl 33):S19-23.
3
Assessment of disease severity and prognosis.
Clin Exp Rheumatol. 2003;21(3 Suppl 29):S42-6.
4
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.
Semin Arthritis Rheum. 2003 Apr;32(5):285-95. doi: 10.1053/sarh.2002.50011.
5
Thrombotic microangiopathies.
Crit Care Clin. 2002 Apr;18(2):309-20, vi. doi: 10.1016/s0749-0704(01)00004-5.
8
[D-dimer in the year 2000: current data and new perspectives].
Ann Ital Med Int. 2000 Oct-Dec;15(4):267-72.
9
Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states.
Thromb Res. 1999 Jan 15;93(2):71-8. doi: 10.1016/s0049-3848(98)00165-0.
10
Plasma D-dimer in the diagnosis of deep vein thrombosis.
JAMA. 1998 Dec 2;280(21):1828-9. doi: 10.1001/jama.280.21.1828-b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验